Previous | Home | EndoTODAY | List | Next
[ÃÖ±Ô¿ë±³¼ö´Ô ÀºÅð±â³ä ½ÉÆ÷Áö¾ö]
¿ø·Î ±³¼ö´ÔÀÇ ÀºÅ𸦠±â³äÇÑ ½ÉÆ÷Áö¾öÀº ¾ðÁ¦³ª ¾Æ¸§´ä½À´Ï´Ù. ¼¿ï¼º¸ðº´¿ø¿¡¼´Â 2014³â 1¿ù 18ÀÏ Åä¿äÀÏ Catholic Digestive Disease SymposiumÀ» ÃÖ±Ô¿ë ±³¼ö´Ô ÀºÅð±â³ä ½ÉÆ÷Áö¾öÀ¸·Î °³ÃÖÇÑ´Ù°í ÇÕ´Ï´Ù. ÃÖ±Ô¿ë ±³¼ö´ÔÀÇ Æ¯º°È¸°í°¿¬ »Ó¸¸ ¾Æ´Ï¶ó serrated pathway, photomedicine, colon cancer screening µî Èï¹Ì·Î¿î ÁÖÁ¦ÀÇ °¿¬ÀÌ ¸¶·ÃµÈ °Í °°½À´Ï´Ù. Àúµµ ²À Âü¼®ÇÏ·Á°í ÇÕ´Ï´Ù. ¿©·¯ºÐ²² ÃßõÇÕ´Ï´Ù.
ÃÖ±Ô¿ë ±³¼ö´Ô. Á¸°æÇÏ°í »ç¶ûÇÕ´Ï´Ù.
2013³â 7¿ù 13ÀÏ EndoTODAY¿¡¼ ¼Ò°³ÇÑ serrated adenoma °³³äÀ» ¾Æ·¡¿¡ ¿Å±é´Ï´Ù.
Serrated polyp (°ÅÄ¡»ó Æú¸³)À̶õ cryptÀÇ ÇüÅ°¡ Å鳯¸ð¾çÀ» ´à¾Ò´Ù´Â Á¡¿¡¼ À¯·¡ÇÑ À̸§ÀÔ´Ï´Ù (serrated = saw-tooth appearance). Crypt epithelial cellÀÇ apoptosis°¡ ÀϾÁö ¾Ê¾Æ¼ ³ëÈµÈ ¼¼Æ÷°¡ ÃàÀûµÊ¿¡ µû¶ó Á¼Àº °ø°£¿¡ ¼¼Æ÷°¡ ½×ÀÌ¸é¼ cryptÀÇ ±¸Á¶°¡ Åé´Ïó·³ µé¾¦³¯¾¦ÇÑ ÇüÅ·Πº¯ÇÑ °ÍÀÔ´Ï´Ù. ºÐ·ù´Â °è¼Ó º¯ÇÏ°í ÀÖÁö¸¸ 2010³â WHO ºÐ·ù´Â ¾Æ·¡ Ç¥¿Í °°½À´Ï´Ù. ¾ÆÁ÷±îÁö´Â ¹«Ã´ ºÒ¿ÏÀüÇÑ ºÐ·ù¹ýÀ̶ó´Â »ý°¢ÀÌ µì´Ï´Ù.
°úÇü¼ºÆú¸³Àº Á¶Á÷ÇÐÀûÀ¸·Î °ÅÄ¡»ó º¯È°¡ ¼±¿ÍÀÇ »óºÎ¿¡ ±¹Çѵ˴ϴÙ. Microvesicular typeÀÌ °¡Àå ÈçÇÑ ÇüÅÂÀÔ´Ï´Ù. µå¹°°Ô sessile serrated adenoma/polypÀ¸·Î ÁøÇàÇÒ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. Goblet cell-rich typeÀº µå¹°°í traditional serrated adenoma·Î ÁøÇàÇÏ´Â °Í °°½À´Ï´Ù. Mucin-poor typeÀº ¸Å¿ì µå¹® ÇüÅÂÀÔ´Ï´Ù.
Sessile serrated adenoma/polyp (SSA/P)Àº ¹«Ã´ ÀÌ»óÇÑ °³³äÀÔ´Ï´Ù. Àüü Æú¸³ÀÇ 5% Á¤µµÀ̸ç, ÇüÅ´ ¹«°æ¼ºÀÌ°í, ºñ¸¸°îºÎ »ó¹æ¿¡¼ ÁÖ·Î ¹ß°ßµË´Ï´Ù. °æ°è´Â ºÒºÐ¸íÇÏ°í ¹ÝÅõ¸íÇϸç Á¡¸ÆÀÌ ¹¯¾îÀÖ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. °ÅÄ¡»ó º¯È°¡ ¼±¿ÍÀÇ ÇϺαîÁö ¹ß»ýÇϸç, ÇϺΠ¼±¿Í°¡ È®ÀåµÇ¾î ÀåÈ°°Àº ¸ð¾çÀ» º¸ÀÔ´Ï´Ù(boot-shaped ȤÀº inverted T-shaped). ƯÀÌÇÑ Á¡Àº dysplasia°¡ ¾ø¾îµµ malignant potentialÀÌ ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ±×·¡¼ dysplasia°¡ ¾ø¾îµµ adenoma¶ó°í ºÒ¸³´Ï´Ù. (ÀÌ»óÇÑ ÀÏÀÌÁö¿ä?) ºñ·Ï celluar atypia´Â ¾øÁö¸¸ structural atypia°¡ Àֱ⠶§¹®¿¡ malignant potentialÀÌ ÀÖ´Â °ÍÀ¸·Î Àú´Â ÀÌÇØÇÏ°í ÀÖ½À´Ï´Ù.
SSA/P¿¡ ÀÌÇü¼ºÀÌ ¹ß»ýÇϸé sessile serrated adenoma/polyp with dysplasia·Î ºÎ¸¨´Ï´Ù. SSA/P with dysplasia´Â MLH1 promoter hypermethylation°ú microsatellite instability¸¦ º¸ÀÌ´Â ´ëÀå¾ÏÀÇ Àü±¸º´º¯ÀÔ´Ï´Ù.
Traditional serrated adenoma (TSA)´Â Àüü ´ëÀå Æú¸²ÀÇ 1%·Î ¸Å¿ì µå¹´´Ï´Ù. Á÷Àå ±Ùó¿¡¼ ¹ß°ßµÇ´Â °æ¿ì°¡ ¸¹À¸¸ç, À¯°æ¼º ¿ëÁ¾ ¶Ç´Â ³ÐÀº ¸ñÀ» °¡Áö°í, µ¹ÃâµÈ ÇüÅÂÀÔ´Ï´Ù. ÀÌ ¶ÇÇÑ Àü¾Ï¼º º´º¯ÀÔ´Ï´Ù.
http://newsblog.mayoclinic.org
ÀÓ»óÀû ÀÇÀÇ¿¡ ´ëÇÏ¿© À嵿°æ ±³¼ö´ÔÀÇ ¿ä¾àÀ» ±×´ë·Î ¿Å±é´Ï´Ù. "Sessile serrated polypÀº ³³ÀÛÇÏ°í °æ°è°¡ ¸íÈ®ÇÏÁö ¾Ê¾Æ barium enema³ª CT colonography·Î´Â ¹ß°ßÀÌ °ÅÀÇ ºÒ°¡´ÉÇÏ°í, ´ëÀå³»½Ã°æÀ¸·Îµµ ³õÄ¡±â ½±´Ù. ÃâÇ÷ÇÏ´Â °æ¿ìµµ ¸Å¿ì µå¹°¾î¼ fecal occult blood test·Î ¹ß°ßÇϱ⵵ ¾î·Æ´Ù. ¾ÏÀ¸·Î ÀÌÇàÇÏ´Â ¼Óµµ°¡ ºü¸£°Ç ´À¸®°Ç °£¿¡ ÀÌ·¯ÇÑ ¹ß°ß»óÀÇ ¾Ö·ÎÁ¡ÀÌ interval cancer·Î ±Í°áµÇ´Â °ÍÀ̶ó´Â ÃßÁ¤µµ ÀÖ´Ù. ±×·¯¹Ç·Î ¿ìÃø ´ëÀåÀÇ ³»½Ã°æ °Ë»ç½Ã¿¡´Â sessile serrated polypÀÇ Á¸À縦 ¿°µÎ¿¡ µÎ°í Á» ´õ ¼¼½ÉÇÏ°Ô °üÂûÇÒ ÇÊ¿ä°¡ ÀÖ´Ù."
Proposed new surveillance guideline for serrated polyps (Terdiman et al. Gastroenterology 2010;139:1444-1447)
1. Serrated polyposisÀÇ Á¤ÀÇ´Â ¹«¾ùÀԴϱî? (2) Á¶Á÷°Ë»ç °á°ú°¡ serrated polypÀ̶ó°í ³ª¿ÀÁö ¾Ê°í hyperplastic polypÀ̶ó°í ³ª¿Íµµ proximal colon¿¡ À§Ä¡ÇÏ´Â µî ¸î °¡Áö Ư¼º¿¡ ¸ÂÀ¸¸é serrated polyposis¶ó°í À̸§ÇÒ ¼ö ÀÖ´Â °ÍÀÎÁö¿ä?
[2013-6-27. ¾Öµ¶ÀÚ Áú¹®] ±³¼ö´Ô ¾È³çÇϼ¼¿ä? º¸³»ÁֽŠ¼ÒÁßÇÑ ³»¿ëÀº ¿½ÉÈ÷ °øºÎÇÏ°í ÀÖ½À´Ï´Ù. 6¿ù 24ÀÏ º¸³»ÁֽŠserrated adenoma ³»¿ë Áß ±Ã±ÝÇÑ °ÍÀÌ ÀÖ¾î ¸ÞÀÏ µå¸³´Ï´Ù. New surveillance guideline for serrated polyps Áß¿¡¼ serrated polyposis¿Í serrated polypÀÇ surveillance intervalÀÌ ¼·Î ´Þ¶ú½À´Ï´Ù. Polyposis¶ó ÇÔÀº FAP µî°ú °°Àº polyposis·Î ÀÌÇØÇØ¾ß ÇÏ´ÂÁö¿ä? ±×¸®°í serrated¶ó ÇÔÀº Á¶Á÷°Ë»ç·Î È®ÀεǴ °ÍÀε¥ serrated polyposis¶ó°í Á¤Àdz»¸®´Â ±âÁØÀÌ ¹«¾ùÀÎÁö¿ä? ÷ºÎµÈ ³í¹®À» ã¾Æº¸´Ï
The criteria for the diagnosis of hyperplastic polyposis, recently renamed serrated polyposis, published by the World Health Organization and the National Comprehensive Cancer Network (NCCN) are as follows:
(1) At least 5 histologically diagnosed HPs proximal to the sigmoid colon, of which 2 are larger than 10 mm in diameter, or
(2) Any number of HPs occurring proximal to the sigmoid colon in an individual who has a first-degree relative with hyperplastic/serrated polyposis (HPSP), or
(3) More than 20 HPs of any size but distributed throughout the colon
À̶ó°í µÇ¾î ÀÖ¾ú½À´Ï´Ù. Hyperplastic polyposis¸¦ serrated polyposis ¶ó°í ´Ù½Ã ¸í¸íÇÒ ¼öµµ ÀÖ´Â °ÇÁöµµ Á¶±Ý ÀǾÆÇÕ´Ï´Ù.^^
[2013-6-27. ´ëÀå Àü¹® H ±³¼ö´Ô²² ¹®ÀÇÇÏ¿© ¹ÞÀº ´äº¯] Á¦°¡ »ý°¢ÇÏ´Â ´äº¯Àº ´ÙÀ½°ú °°½À´Ï´Ù. (¾à°£ÀÇ ÁÖ°üÀÌ °³ÀԵǾî ÀÖ½À´Ï´Ù )
1. Serrated polyposis¿Í serrated polyp´Â surveillance °£°ÝÀÌ ´Ù¸¥ °ÍÀº ¾î¶»°Ô ÀÌÇØÇÏ¿©¾ß Çմϱî?
-> Familiar adennomatous polyposis (FAP)¿Í tubular adenomaÀÇ surveillance interval ÀÌ ´Ù¸¥ °Íó·³ »ý°¢ÇϽøé ÁÁ°Ú½À´Ï´Ù.
2. Polyposis¶ó ÇÔÀº FAP µî°ú °°Àº polyposis·Î ÀÌÇØÇØ¾ß ÇÏ´ÂÁö¿ä?
-> ³×, ÀϹÝÀûÀ¸·Î polyposis¶ó°í Çϸé ÀüÅëÀûÀ¸·Î 100°³ ÀÌ»óÀ» À̾߱âÇÏÁö¸¸, ½Ã°£ÀÌ Áö³ª¸é¼ attenuated FAP ȤÀº MYH polyposisµî°ú °°ÀÌ 30 (Àû°Ô´Â 10 or 20) ~ 100 »çÀÌÀÇ polypÀÌ Á¸ÀçÇÏ´Â °æ¿ìµµ polyposis¶ó°í ÇÕ´Ï´Ù. Hyperplastic/serrated polyposis (HPSP)µµ 20°³ ÀÌ»óÀÇ SP(HP)°¡ ÀÖÀ¸¸é Áø´ÜµÇ¹Ç·Î ±×·¸°Ô ÀÌÇØÇϼŵµ ¹®Á¦´Â ¾ø½À´Ï´Ù.
3. Serrated polypÀº Á¶Á÷°Ë»ç·Î È®ÀεǴ °ÍÀε¥ serrated polyposis¶ó°í Á¤ÀÇÇÏ´Â ±âÁØÀº ¹«¾ùÀÎÁö¿ä?
-> ¾Õ¼ ¾ð±ÞÇØ µå¸° multiple HP¿Ü¿¡µµ 2°³ ÀÌ»óÀÇ 1cm ÀÌ»óÀÇ large SP¸¦ Æ÷ÇÔÇÏ´Â 5°³ ÀÌ»óÀÇ proximal SP/HP°¡ Á¸ÀçÇÏ´Â °Í°ú serrated polyposis(SPS)ÀÇ 1Â÷ °¡Á··ÂÀÌ ÀÖÀ¸¸é¼ HP/SP°¡ Á¸ÀçÇÏ´Â °æ¿ì¸¦ Æ÷ÇÔÇÏ¿© SPS¶ó°í ÇÕ´Ï´Ù.
´Ù¸¥ polypsis¿Í ´Þ¸® serrated polyposis(SPS)´Â heterogenousÇÏ¸é¼ uniqueÇÑ genetic mutationÀÌ ¾ø½À´Ï´Ù. Serrated polyposisµµ Æò»ý ´©Àû ´ëÀå¾Ï ¹ß»ý·üÀÌ 25-70%·Î ³ô±â ¶§¹®¿¡ ÀϹÝÀûÀÎ SP/HP¿Í ´Þ¸® intensive surveillance°¡ ÇÊ¿äÇÕ´Ï´Ù.
2. Hyperplastic polyposis¿Í serrated polyposis´Â °á±¹ °°Àº °ÍÀԴϱî?
[2013-6-28. ´ëÀå Àü¹® H ±³¼ö´Ô²² ¹®ÀÇÇÏ¿© ¹ÞÀº ´äº¯] ³×. µ¿ÀÏÇÏ´Ù°í »ý°¢Çصµ µÇ°í ½ÇÁ¦ ÀÓ»ó ¹× ½ÇÇè research paper·Î º¸¼Åµµ µ¿ÀÏÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÇÁ¦ serrated (hyperplastic) polyposisÀÇ ÇÙ½ÉÀº SSA/P¿¡ ÀÖ½À´Ï´Ù. °ú°Å sessile serrated adenoma/polypÀÌ hyperplastic polypÀ¸·Î ºÐ·ùµÇ¾ú´ø ½Ã±â¿¡´Â hyperplastic polyposis·Î ĪÇÏ´ø Áúº´ÀÌ ÃÖ±Ù SSA/P°¡ ºñ±³Àû ¸íÈ®È÷ ±¸ºÐµÇ¸é¼ serrated polypsis·Î ¹Ù²ã ºÎ¸£°Ô µÈ °ÍÀÔ´Ï´Ù.